Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol
- 7 August 2004
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 15 (1) , 75-84
- https://doi.org/10.1016/j.euroneuro.2004.06.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective DisordersThe Journal of Clinical Psychiatry, 2001
- Prophylaxis of bipolar disorder: how and who should we treat in the long term?European Neuropsychopharmacology, 1999
- Medication Treatment for the Severely and Persistently Mentally IllThe Journal of Clinical Psychiatry, 1999
- A combined analysis of double‐blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptomsActa Psychiatrica Scandinavica, 1999
- Long-term risperidone treatment in bipolar disorderInternational Clinical Psychopharmacology, 1997
- Mortality in affective disorderJournal of Affective Disorders, 1994
- Tardive Dyskinesia in Bipolar Affective DisorderInternational Clinical Psychopharmacology, 1991
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962